Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|March 12, 2005
The effects of subunit composition on the inhibition of nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl heptanoateRoger L Papke, Joshua D Buhr, Michael M Francis, et al.
European Journal of Medicinal Chemistry|August 19, 2020
Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activationMaria Chiara Pismataro, Nicole A Horenstein, Clare Stokes, et al.
Molecular Pharmacology|June 24, 2004
The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptorsClare Stokes, Julia Kay Porter Papke, Nicole A Horenstein, et al.
Human Immunology|May 11, 2023
Immune-regulatory properties carried by human amnion epithelial cells: Focus on the role of HLA-G and adenosinergic ectoenzymesF Morandi, I Airoldi, A Faini, et al.
Molecular Pharmacology|July 22, 2020
Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of <i>α</i>7 nAChRRoger L Papke, Sumanta Garai, Clare Stokes, et al.
The Journal of Biological Chemistry|January 9, 2016
Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATIONNicole A Horenstein, Roger L Papke, Abhijit R Kulkarni, et al.
Chemmedchem|May 12, 2017
Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ<sup>2</sup> -Isoxazoline Scaffold: Synthesis and Electrophysiological EvaluationMarta Quadri, Carlo Matera, Almin Silnović, et al.
Journal of Medicinal Chemistry|September 9, 2017
Sulfonium as a Surrogate for Ammonium: A New α7 Nicotinic Acetylcholine Receptor Partial Agonist with Desensitizing ActivityMarta Quadri, Clare Stokes, Alican Gulsevin, et al.
European Journal of Medicinal Chemistry|October 21, 2018
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluationMarta Quadri, Almin Silnović, Carlo Matera, et al.
The Journal of Biological Chemistry|December 24, 2013
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interfaceRoger L Papke, Nicole A Horenstein, Abhijit R Kulkarni, et al.
Pageof 8